Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or OpenAthens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Commentary

Free Access

Expectations and Projections for the Future of Nongynecolgical Cytology 10 Years Ago: Did They Materialize and How Did We Do?

Schmitt F.C.a, b · Vielh P.c

Author affiliations

aInstitute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), and bDepartment of Pathology and Oncology, Medical Faculty, University of Porto, Porto, Portugal; cLaboratoire National de Santé, Dudelange, Luxembourg

Corresponding Author

Correspondence to: Prof. Fernando C. Schmitt

IPATIMUP

Rua Júlio Amaral de Carvalho, 45

PT-4200-135 Porto (Portugal)

E-Mail fernando.schmitt@ipatimup.pt

Related Articles for ""

Acta Cytologica 2017;61:373-407

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Abstract

In 2007, an article entitled “How Technology Is Reshaping the Practice of Nongynecologic Cytology: Frontiers of Cytology Symposium” [Bibbo: Acta Cytol 2007;51:123-152] was published. The moderator and editor was Marluce Bibbo, previous Editor-in-Chief of Acta Cytologica, and 17 participants from countries throughout the world were asked to answer how new technologies were being applied in their respective laboratories and whether future advances and challenges can be predicted. Ten years later, two previous participants in this Golden Anniversary Cytology Symposium were asked by Kari Syrjänen, current Editor-in-Chief of Acta Cytologica, to make a reappraisal of the 2007 predictions.

© 2017 S. Karger AG, Basel


References

  1. Bibbo M: How technology is reshaping the practice of nongynecologic cytology: frontiers of cytology symposium. Acta Cytol 2007;51:123-152.
  2. Syrjanen K: Sixty Years of Acta Cytologica. Acta Cytol 2017;61:1-2.
  3. Roy-Chowdhuri S, Goswami RS, Chen H, Patel KP, Routbort MJ, Singh RR, et al: Factors affecting the success of next-generation sequencing in cytology specimens. Cancer Cytopathol 2015;123:659-668.
  4. Marinsek ZP, Nolde N, Skelin IK, Nizzoli R, Onal B, Rezanko T, et al: Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates. Cytopathol 2013;24:7-20.
  5. Nobre AR, Albergaria A, Schmitt F: p40: A p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63. Acta Cytol 2013;57:1-8.
  6. Selinger CI, Li BT, Pavkalis N, Links M, Gill AJ, Lee A, et al: Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target. Histopathology 2017;70:402-411.
  7. Miki Y, Neat M, Chandra A: Application of the Paris System to atypical urine cytology samples: correlation with histology and UroVysion FISH. Cytopathology 2017;28:88-95.
  8. Flores-Staino C, Darai-Ramqvist E, Dobra K, Hjerpe A: Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions. Lung Cancer 2010;68:39-43.
  9. Dudley JC, Zheng Z, McDonald T, Le LP, Dias-Santagata D, Borger D, et al: Next-generation sequencing and fluorescence in situ hybridization have comparable performance characteristics in the analysis of pancreaticobiliary brushings for malignancy. J Mol Diagn 2016;18:124-130.
  10. Lorito Di A, Schmitt F: (Cyto)Pathology and sequencing: next (or last) generation? Diagn Cytopathol 2011;40:459-461.
  11. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011;6:244-285.
  12. Bernadt CT, Collins BT: Fine-needle aspiration biopsy of HPV-related squamous cell carcinoma of the head and neck: current ancillary testing methods for determining HPV status. Diagn Cytopathol 2017;45:221-229.
  13. Schmitt FC: Molecular cytopathology and flow cytometry: pre-analytical procedures matter. Cytopathology 2011;22:355-357.
  14. Malapelle U, de Las Casas CM, Molina M, Rosell R, Spasenija S, Bihl M, et al: Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: a worldwide ring trial study on quantitative cytological molecular reference specimens. Cancer 2017, DOI: 10.1002/cncy.21868.
  15. Longatto-Filho A, Schmitt FC: Cytology education in the 21st century: living in the past or crossing the rubicon? Acta Cytol 2010;54:654-656.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Commentary

Received: May 22, 2017
Accepted: May 23, 2017
Published online: July 11, 2017
Issue release date: July – October

Number of Print Pages: 35
Number of Figures: 0
Number of Tables: 0

ISSN: 0001-5547 (Print)
eISSN: 1938-2650 (Online)

For additional information: https://www.karger.com/ACY

References

  1. Bibbo M: How technology is reshaping the practice of nongynecologic cytology: frontiers of cytology symposium. Acta Cytol 2007;51:123-152.
  2. Syrjanen K: Sixty Years of Acta Cytologica. Acta Cytol 2017;61:1-2.
  3. Roy-Chowdhuri S, Goswami RS, Chen H, Patel KP, Routbort MJ, Singh RR, et al: Factors affecting the success of next-generation sequencing in cytology specimens. Cancer Cytopathol 2015;123:659-668.
  4. Marinsek ZP, Nolde N, Skelin IK, Nizzoli R, Onal B, Rezanko T, et al: Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates. Cytopathol 2013;24:7-20.
  5. Nobre AR, Albergaria A, Schmitt F: p40: A p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63. Acta Cytol 2013;57:1-8.
  6. Selinger CI, Li BT, Pavkalis N, Links M, Gill AJ, Lee A, et al: Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target. Histopathology 2017;70:402-411.
  7. Miki Y, Neat M, Chandra A: Application of the Paris System to atypical urine cytology samples: correlation with histology and UroVysion FISH. Cytopathology 2017;28:88-95.
  8. Flores-Staino C, Darai-Ramqvist E, Dobra K, Hjerpe A: Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions. Lung Cancer 2010;68:39-43.
  9. Dudley JC, Zheng Z, McDonald T, Le LP, Dias-Santagata D, Borger D, et al: Next-generation sequencing and fluorescence in situ hybridization have comparable performance characteristics in the analysis of pancreaticobiliary brushings for malignancy. J Mol Diagn 2016;18:124-130.
  10. Lorito Di A, Schmitt F: (Cyto)Pathology and sequencing: next (or last) generation? Diagn Cytopathol 2011;40:459-461.
  11. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011;6:244-285.
  12. Bernadt CT, Collins BT: Fine-needle aspiration biopsy of HPV-related squamous cell carcinoma of the head and neck: current ancillary testing methods for determining HPV status. Diagn Cytopathol 2017;45:221-229.
  13. Schmitt FC: Molecular cytopathology and flow cytometry: pre-analytical procedures matter. Cytopathology 2011;22:355-357.
  14. Malapelle U, de Las Casas CM, Molina M, Rosell R, Spasenija S, Bihl M, et al: Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: a worldwide ring trial study on quantitative cytological molecular reference specimens. Cancer 2017, DOI: 10.1002/cncy.21868.
  15. Longatto-Filho A, Schmitt FC: Cytology education in the 21st century: living in the past or crossing the rubicon? Acta Cytol 2010;54:654-656.
    External Resources

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.